Literature DB >> 2859874

The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration.

J L Shaffer, J B Houston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2859874      PMCID： PMC1463819          DOI： 10.1111/j.1365-2125.1985.tb02682.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Pharmacological implications of microsomal enzyme induction.

Authors:  A H Conney
Journal:  Pharmacol Rev       Date:  1967-09       Impact factor: 25.468

2.  Azo reduction of sulphasalazine in healthy volunteers.

Authors:  J B Houston; J Day; J Walker
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

3.  Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.

Authors:  U Klotz; K Maier; C Fischer; K Heinkel
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

4.  Controlled trial of rifampicin and ethambutol in Crohn's disease.

Authors:  J L Shaffer; S Hughes; B D Linaker; R D Baker; L A Turnberg
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.

Authors:  H Schröder; R M Lewkonia; D A Price Evans
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

6.  Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.

Authors:  K A Hansson; M Sandberg
Journal:  Acta Pharm Suec       Date:  1973-03

Review 7.  Rifampicin, a general review.

Authors:  G Binda; E Domenichini; A Gottardi; B Orlandi; E Ortelli; B Pacini; G Fowst
Journal:  Arzneimittelforschung       Date:  1971-12

Review 8.  Clinical pharmacokinetics of sulphasalazine.

Authors:  K M Das; R Dubin
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of rifampicin.

Authors:  G Acocella
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

10.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine.

Authors:  P A van Hees; J H Bakker; J H van Tongeren
Journal:  Gut       Date:  1980-07       Impact factor: 23.059
View more
  4 in total

Review 1.  Clinically significant interactions with drugs used in the treatment of tuberculosis.

Authors:  W W Yew
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease.

Authors:  J L Shaffer; A Kershaw; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 3.  Pharmacokinetic drug interactions with rifampicin.

Authors:  K Venkatesan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

Review 4.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.